Protalix BioTherapeutics (PLX) Change in Cash (2010 - 2026)
Protalix BioTherapeutics' quarterly Change in Cash came in at $26.3 million in Q1 2026, up 8815.56% year-on-year from $295225.3 in Q1 2025, and up 2448.02% quarter-over-quarter from $1.0 million in Q4 2025.
Protalix BioTherapeutics has reported Change in Cash for 17 years, with the latest figure at $26.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 8815.56% year-over-year to $26.3 million; the trailing twelve-month figure through Mar 2026 stood at $21.5 million (up 377.94% YoY), and the FY2025 full-year result was -$5.1 million, down 31.13% from the prior year.
- Change in Cash for Q1 2026 stood at $26.3 million, up from $1.0 million in the prior quarter.
- The five-year high for Change in Cash was $26.3 million in Q1 2026, with the low at -$27.8 million in Q3 2023.
- Average Change in Cash over 5 years is $118588.2, with a median of -$302000.0 recorded in 2025.
- Year-over-year, Change in Cash tumbled 1511.95% in 2022 and surged 8815.56% in 2026.
- Tracing PLX's Change in Cash over 5 years: stood at $6.4 million in 2022, then plunged by 49.52% to $3.2 million in 2023, then slumped by 337.1% to -$7.6 million in 2024, then soared by 113.51% to $1.0 million in 2025, then soared by 2448.02% to $26.3 million in 2026.
- The last three Change in Cash figures came in at $26.3 million (Q1 2026), $1.0 million (Q4 2025), and -$4.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 26.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.32 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | -4.25 Mn |
| Jun 30, 2025 | -1.56 Mn |
| Mar 31, 2025 | -302,000.00 |
| Dec 31, 2024 | -7.65 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | -3.81 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 3.23 Mn |
| Sep 30, 2023 | -27.78 Mn |
| Jun 30, 2023 | 15.15 Mn |
| Mar 31, 2023 | 15.93 Mn |
| Dec 31, 2022 | 6.39 Mn |
| Sep 30, 2022 | -1.77 Mn |
| Jun 30, 2022 | -4.40 Mn |
| Mar 31, 2022 | -22.10 Mn |
| Dec 31, 2021 | 28.34 Mn |
| Sep 30, 2021 | -23.24 Mn |
| Jun 30, 2021 | 14.05 Mn |
| Mar 31, 2021 | 1.57 Mn |
| Dec 31, 2020 | 4.73 Mn |
| Sep 30, 2020 | 8.69 Mn |
| Jun 30, 2020 | -9.32 Mn |
| Mar 31, 2020 | -3.63 Mn |
| Dec 31, 2019 | -3.65 Mn |
| Sep 30, 2019 | -3.65 Mn |
| Jun 30, 2019 | -5.27 Mn |
| Mar 31, 2019 | -7.45 Mn |
| Dec 31, 2018 | -4.06 Mn |
| Sep 30, 2018 | 13.54 Mn |
| Jun 30, 2018 | -12.99 Mn |
| Mar 31, 2018 | -9.84 Mn |
| Dec 31, 2017 | 17.68 Mn |
| Sep 30, 2017 | -1.05 Mn |
| Jun 30, 2017 | -13.48 Mn |
| Mar 31, 2017 | -15.26 Mn |
| Dec 31, 2016 | 11.96 Mn |
| Sep 30, 2016 | -3.31 Mn |
| Jun 30, 2016 | -12.04 Mn |
| Mar 31, 2016 | -9.71 Mn |
| Dec 31, 2015 | 42.13 Mn |
| Sep 30, 2015 | -8.99 Mn |
| Jun 30, 2015 | -4.72 Mn |
| Mar 31, 2015 | -6.81 Mn |
| Mar 31, 2014 | -8.71 Mn |
| Dec 31, 2013 | -5.00 Mn |
| Sep 30, 2013 | 58.27 Mn |
| Jun 30, 2013 | -8.74 Mn |
| Mar 31, 2013 | -10.17 Mn |
| Dec 31, 2012 | 1.82 Mn |
| Sep 30, 2012 | -9.06 Mn |
| Jun 30, 2012 | 13.68 Mn |
| Mar 31, 2012 | 18.60 Mn |
| Dec 31, 2011 | -7.56 Mn |
| Sep 30, 2011 | -9.49 Mn |
| Jun 30, 2011 | -6.17 Mn |
| Mar 31, 2011 | 14.33 Mn |
| Dec 31, 2010 | -8.50 Mn |
| Sep 30, 2010 | -10.56 Mn |